Stockreport

BioCryst feels Gilead's remdesivir pain, down 9% [Seeking Alpha]

BioCryst Pharmaceuticals, Inc.  (BCRX) 
Last biocryst pharmaceuticals, inc. earnings: 3/5 07:05 am Check Earnings Report
US:NASDAQ Investor Relations: biocryst.gcs-web.com/investor-relations
PDF BioCryst Pharmaceuticals (BCRX-8.7%GILD-5.0%BioCryst is testing its own antiviral, galidesivir, for the same use. A Phase 1 study in Brazil is in process. [Read more]